Related Experiment Video

Updated: Jul 7, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?

Stephanie Syc-Mazurek1, John J Chen1

  • 1Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN, USA; Center of MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|July 6, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Live Imaging and Characterization of Microglia Dynamics and Interactions with Synapses in Diseased Murine Retina
07:19

Live Imaging and Characterization of Microglia Dynamics and Interactions with Synapses in Diseased Murine Retina

Published on: January 16, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
09:46

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

Related Experiment Videos

Last Updated: Jul 7, 2026

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

Live Imaging and Characterization of Microglia Dynamics and Interactions with Synapses in Diseased Murine Retina
07:19

Live Imaging and Characterization of Microglia Dynamics and Interactions with Synapses in Diseased Murine Retina

Published on: January 16, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
09:46

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

Published on: July 15, 2025

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Articles linked to this work by shared authors, journal, and citation graph.

Effectiveness and Safety of Plasmapheresis in MOGAD Attacks: A Systematic Review and Meta-Analysis.

Neurology·2026

Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSD.

Journal of neurology, neurosurgery, and psychiatry·2026

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results.

Neurology(R) neuroimmunology & neuroinflammation·2026

Investigating the Frequency and Outcome of Central Vein Sign and Paramagnetic Rim Lesions in Children With MOGAD.

Neurology·2026

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

Neurology(R) neuroimmunology & neuroinflammation·2026

MKK4 and MKK7 control degeneration of retinal ganglion cell somas and axons after glaucoma-relevant injury.

Cell death discovery·2025

Shared etiology of late- and adult-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Borrelia miyamotoi meningoradiculitis complicating ocrelizumab treatment for multiple sclerosis: A report of three cases.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Saturated fatty acids enhance daptomycin activity in a Fak-dependent manner in enterococci.

Microbiology (Reading, England)·2026

Growing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model.

Infection and immunity·2026

Intramuscular Antibiotics Modify Infectious Outcomes in Contaminated, Ischemic Limbs.

Military medicine·2026

Risk Factors for Disease in Military Working Equines.

Military medicine·2026

From decline to resurgence: current perspectives on Mycoplasma pneumoniae.

Clinical microbiology reviews·2026

Possible Contribution of Multiple Sclerosis Pathology to Treatment-Resistant Schizophrenia: A Case Study.

Neuropsychopharmacology reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us